ImmPACT Bio Revenue and Competitors
Estimated Revenue & Valuation
- ImmPACT Bio's estimated annual revenue is currently $20.6M per year.
- ImmPACT Bio's estimated revenue per employee is $155,000
Employee Data
- ImmPACT Bio has 133 Employees.
- ImmPACT Bio grew their employee count by 36% last year.
ImmPACT Bio's People
Name | Title | Email/Phone |
---|
ImmPACT Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is ImmPACT Bio?
ImmPACT Bio is dedicated to the discovery of transformative CAR-T cell therapies for cancer patients who have exhausted their treatment options. Our technology is designed to precisely distinguish cancerous cells from normal cells; thereby eliminating tumors without damaging normal tissues. Our goal is to eradicate tumors without generating the severe side effects that are difficult, sometimes impossible, for cancer patients to endure. The company was founded in 2017 in the FuturRx incubator (Israel). In 2019, ImmPACT Bio was incorporated in the US and R&D operations were established in Camarillo, CA. In 2021 ImmPACT Bio merged with Kalthera.
keywords:N/AN/A
Total Funding
133
Number of Employees
$20.6M
Revenue (est)
36%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $194.4M | 471 | 1% | $40M |